MNKDのPER（株価収益率）は？

MANNKIND CORP（MNKD）は現在PER 146.75倍で取引されています。

MNKDのROE（自己資本利益率）は？

MANNKIND CORPのROEは40.40%です。

MNKDの配当利回りは？

MANNKIND CORPの配当利回りは0.00%です。

MNKDの品質スコア（Quality Score）は？

当社のAIはMNKDの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

MNKDは今が買い時ですか？

当社AIのタイミングスコアは100点中67点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

MNKDはどのセクターに属しますか？

MANNKIND CORPはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

MNKD (NASDAQ) 株価分析 | MANNKIND CORP

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

MNKD AI Analysis Summary

Our AI summary for MNKD: MANNKIND CORP (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 146.75, ROE of 40.40%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

MNKD

MANNKIND CORP

US:NASDAQ STOCK Healthcare >> Biotechnology News 92

USD 3.91

-0.20 (-4.87%) Day Change

Watchlist Portfolio Compare Chart

146.75

P/E

-5.60

D/E

40.4%

ROE

-3.2%

ROA

0.00%

Div Yield

-0.91

PEG

MANNKIND CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.91 Price -0.20 (-4.87%) Day Change	NEWS SCORE: 92

MNKD, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	92
Magic Formula Rank by ROA	3053
Magic Formula Rank by ROE	3053
Magic Formula Rank by ROIC	3013
Price	3.91
PBV / Sector	-21.45 / 5.20
Earning Per Share	-0.07

PE / Sector	146.75 / 19.97
PEG or PE/Growth / Sector	-0.91 / 1.22
Average 1M Daily Value	18.08 M GREAT
Average 1W Daily Value	17.34 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-6.63 / 98.71
NPM Average (%) / Sector	-17.78 / -1,721.76
NPM Change Average (%) / Sector	-232.83 / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-3.21 / 27.02
ROA Average (%) / Sector	-5.52 / -368.17
ROA Change Average (%) / Sector	-273.46 / 5,404.12
ROE (%) / Sector	40.40 / 3.47 GREAT
ROE Average (%) / Sector	6.73 / 6.51
ROE Change Average (%) / Sector	-356.65 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 08:00:11
Symbol	MNKD
Name	MANNKIND CORP
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	308.95 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,269.79 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1 Casper Street, Danbury, CT, United States, 06810

Phone: 818 661 5000

Website: https://mannkindcorp.com

Employees: 591

Sector: Healthcare >> Biotechnology

Description: MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. Its products also include Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; FUROSCIX, a furosemide injection to treat fluid buildup in patients with chronic heart failure or chronic kidney disease. The company's pipeline of treatments for orphan lung diseases include MNKD-201, a dry-powder formulation of nintedanib for the treatment of idiopathic pulmonary fibrosis and MNKD-701. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.